Exhibit 10.33
 
GENEREX BIOTECHNOLOGY CORPORATION

Annual Base Salaries for Executive Officers Effective January 1, 2008
 
On May 6, 2008, the Board of Directors of Generex Biotechnology Corporation
implemented changes in annual base salary for its executive officers retroactive
to the effective date of January 1, 2008 as follows:
  
 
 
Annual Base Salary
 
Executive Officer
 
Increase
Effective as of January 1, 2008
 
Anna E. Gluskin
Chairman of the Board of Directors, President and Chief Executive Officer
 
$
525,000
 
Rose C. Perri
Chief Operating Officer, Chief Financial Officer, Treasurer Secretary and
Director
 
$
420,000
 
Mark Fletcher
Executive Vice President and General Counsel
 
$
315,000
 

--------------------------------------------------------------------------------